TGCA
Live / Registered — Registered (as of 09 Jun 2020)
What this means for you
Registered since 09 Jun 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88422345
- Registration number
- 6072598
- Mark type
- Stylized text
- Filed
- 09 May 2019
- Published for opposition
- 24 Mar 2020
- Registered
- 09 Jun 2020
- Attorney of record
- Devon E. White
Goods and services
- Class 035 — Advertising and business services: Business management and consultation services in the field of specialty pharmacy, pharmaceutical manufacturers, genetic medicine and therapies, RNA based therapeutics, cell therapies and gene-modified cell therapies, pharmacy benefit managers, physicians, health systems; Business risk management, consulting and information services in the field of specialty pharmacy, pharmaceutical manufacturers, genetic medicine and therapies, RNA based therapeutics, cell therapies and gene-modified cell therapies, pharmacy benefit managers, physicians, health systems; Business marketing consulting services; Business consulting services in the field of pharmaceutical and drug development
- Class 041 — Education and entertainment services: Educational services in the field of specialty pharmacy, genetic medicine and therapies, RNA based therapeutics, cell therapies and gene-modified cell therapies, pharmacogenetics, pharmacy payer and reimbursement, therapeutic patient care risk analysis and management, and pharmacy manufacturing, in face-to-face and web-based courses, seminars, workshops and training sessions; Educational services in the field new therapies and risk management for patient care in face-to-face and web-based courses, seminars, workshops and training sessions; Educational services provided to stakeholders, namely, Pharmaceutical Manufacturers, Payers, PBMS, Health Systems, IDN's, Physicians, Specialty Pharmacies, and patients and in the field of genetic therapies and pharmacogenetics in face-to-face and web-based courses, seminars, workshops and training sessions; Providing an educational website portal for providers and patients featuring non-downloadable videos in the field of specialty pharmacies, pharmaceutical manufacturers, genetic medicine and therapies, RNA based therapeutics, cell therapies and gene-modified cell therapies, pharmacy benefit managers, physicians, health systems; Providing an educational website portal for providers and patients featuring non-downloadable videos in the field of new therapies and risk management; Research services, namely, the design and development of data collection methodologies, the collection of data, and the reporting of results for developing training systems and learning methodologies for others
- Class 042 — Scientific and technological services: Research services, namely, providing customized studies of data and research, namely, medical and scientific research services; Research services, namely, the design and development of data collection methodologies, the collection of data, and the reporting of results for medical research and scientific research purposes; Providing research and support services for the management and reporting of outcomes of therapies, namely, for medical research and scientific research purposes
Owner
- Therapeutic Genetics Consulting Associates LLC, Chapel Hill, NC, US
- Therapeutic Genetics Consulting Associates LLC, Chapel Hill, NC, US
- Therapeutic Genetics Consulting Associates LLC, Chapel Hill, NC, US
Prosecution history
- 09 Jun 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 09 Jun 2020 — REGISTERED-PRINCIPAL REGISTER
- 24 Mar 2020 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 24 Mar 2020 — PUBLISHED FOR OPPOSITION
- 04 Mar 2020 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 18 Feb 2020 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 29 Jan 2020 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 29 Jan 2020 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 29 Jan 2020 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 31 Jul 2019 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 31 Jul 2019 — NON-FINAL ACTION E-MAILED
- 31 Jul 2019 — NON-FINAL ACTION WRITTEN
- 25 Jul 2019 — ASSIGNED TO EXAMINER
- 23 May 2019 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 13 May 2019 — NEW APPLICATION ENTERED